Soon mRNA vaccines for young children who rarely suffer from severe disease

Young children rarely suffer from severe disease, yet mRNA vaccines might soon be greenlighted by the FDA after Pfizer submitted Phase-2/3 data for initial review. The company expects to submit data of children 2-4 years and 6 months to 1 year by the end of the year. Vaccinating young children while even health-care workers in … Continue reading Soon mRNA vaccines for young children who rarely suffer from severe disease

180 deaths following COVID-19 vaccination reported in India

When deaths after vaccination are assessed on a weekly basis, more deaths are seen in the first week than two-four weeks. Of the 124 deaths that have been categorised, 111 deaths have been in the first week (nearly 16 deaths per day) but only 11 deaths (0.5 deaths per day) in the next three weeks. … Continue reading 180 deaths following COVID-19 vaccination reported in India

Vaccinate all above 45 years to avoid vaccine inequities

While the intent of the government to quickly protect people with comorbidities above the age of 45 years who are at greater risk of progressing to severe form of disease or even death is commendable, any insistence on documentary evidence for vaccination will be hugely counterproductive. Similarly, insisting on prior registration on the CoWIN platform … Continue reading Vaccinate all above 45 years to avoid vaccine inequities

Causality assessment of COVID-19 vaccine deaths will be made public, says National AEFI Committee advisor

Vaccine as a biological cause is least likely to cause deaths. The adenovirus vector and the genetic material that helps in making the spike protein are unlikely to cause deaths. But other ingredients in the vaccine and the quality of the vaccine in the particular batches that were used in these situations should be investigated. … Continue reading Causality assessment of COVID-19 vaccine deaths will be made public, says National AEFI Committee advisor